Insulin signaling pathway

Insulin secretion

Insulin resistance

INS; insulin

INSR, CD220; insulin receptor [EC:2.7.10.1]

INSRR; insulin receptor-related receptor [EC:2.7.10.1]

IGF1R, CD221; insulin-like growth factor 1 receptor [EC:2.7.10.1]

INSL6; insulin-like 6

K23575 insulin-like growth factor-binding protein 2 | (RefSeq) IGFBP2, IBP2, IGF-BP53; insulin like growth factor binding protein 2

K21999 insulin-like 3 | (RefSeq) INSL3, RLF, RLNL, ley-I-L; insulin like 3

K06827 connective tissue growth factor (insulin-like growth factor-binding protein 8) | (RefSeq) CCN2, CTGF, HCS24, IBP-8, IGFBP8, NOV2; cellular communication network factor 2

K17446 insulin receptor substrate 4 | (RefSeq) IRS4, CHNG9, IRS-4, PY160; insulin receptor substrate 4

K07187 insulin receptor substrate 2 | (RefSeq) IRS2, IRS-2; insulin receptor substrate 2

K16172 insulin receptor substrate 1 | F1-U_079C10.y_B_pred_1_+_1_61_1_P

K26681 insulin-induced protein | F2-V_043O07.y_B_pred_2_-_817_914_2_P

K16172 insulin receptor substrate 1 | F2-W_066P21.z_B_pred_3_-_1056_1119_1_P

K07187 insulin receptor substrate 2 | In-A_075O23.b_B_pred_4_-_937_1069_1_P

K06827 connective tissue growth factor (insulin-like growth factor-binding protein 8) | In-E_058B14.g_B_pred_3_+_1006_1097_0_P

Insulin

Reduced insulin

Glucose-dependent insulinotropic peptide; Gastric inhibitory peptide; GIP

Insulin-like 3; Relaxin-like factor; INSL 3

Insulin-like growth factor I; Somatomedin C

glutathione:insulin oxidoreductase; Insulin + 2 Glutathione <=> Reduced insulin + Glutathione disulfide

protein-disulfide reductase; protein disulphide reductase; insulin-glutathione transhydrogenase; disulfide reductase; NAD(P)H2:protein-disulfide oxidoreductase

protein-disulfide reductase (glutathione); glutathione-insulin transhydrogenase; insulin reductase; reductase, protein disulfide (glutathione); protein disulfide transhydrogenase; glutathione-protein disulfide oxidoreductase; protein disulfide reduc • • •

receptor protein-tyrosine kinase; AATK; AATYK; AATYK2; AATYK3; ACH; ALK; anaplastic lymphoma kinase; ARK; ATP:protein-tyrosine O-phosphotransferase (ambiguous); AXL; Bek; Bfgfr; BRT; Bsk; C-FMS; CAK; CCK4; CD115; CD135; CDw135; Cek1; Cek10; Cek11; C • • •

carboxypeptidase E; carboxypeptidase H; enkephalin convertase; cobalt-stimulated chromaffin granule carboxypeptidase; insulin granule-associated carboxypeptidase; enkephalin convertase; membrane-bound carboxypeptidase; carboxypeptidase E; enkephalin • • •

insulysin; insulinase; insulin-degrading enzyme; insulin protease; insulin proteinase; insulin-degrading neutral proteinase; insulin-specific protease; insulin-glucagon protease; metalloinsulinase; IDE

Insulin-resistant diabetes mellitus with acanthosis nigricans; Type A insulin resistance

Familial hyperinsulinemic hypoglycemia

Growth delay due to insulin-like growth factor I resistance; IGF-I resistance

Hypoinsulinemic hypoglycemia with hemihypertrophy

Insulin-like growth factor I deficiency

Insulin (JAN/USP)

Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN)

Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN)

Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN)

Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN)

Insulin preparation

Insulin sensitizer

Glinide; Meglitinide; Short acting insulin secretagogues

Insulin analog, fast-acting

Insulin analog, long-acting